Achieve Clinical Data Transparency with the 4 Cs of Collaboration Blog Post
In this blog, we look at how you can enhance clinical data transparency and make data informed decisions with the 4 Cs of collaboration.
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region Blog Post
Abstract The integration of MID3 offers a transformative opportunity for the MENA region to advance pharmaceutical research and healthcare through sophisticated quantitative models like population PK/PD and PBPK modeling. 教育资源...
Simcyp™ In Vitro Data Analysis (SIVA) Toolkit Blog Post
Download PDF
Unlock Global Regulatory Success: Overcoming Early Drug Development Challenges [APAC Webinar] Blog Post
Summary Navigating early drug development is critical to ensuring the long-term success of therapeutic candidates. 本次网络研讨会将探讨克服常见挑战的关键策略，并分享来自亚太地区和美国的专家见解。...
Why FDA’s omaveloxolone approval for Friedreich’s ataxia matters Blog Post
Rajesh Krishna, PhD 2025 年 1 月 10 日 Friedreich’s Ataxia (FA) is a rare, genetic, and progressive neurodegenerative disorder. A defect in the Frataxin (FXN) gene causes FA. FXN is essential for...
Certara Appoints New Head of Biometrics, Data Science, and Access Blog Post
2025 年 1 月 10 日 RADNOR, PA. – 2025 年 1 月 10 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, today announced the appointment of Tiffany Woodworth as Head of Biometrics, Data...
Solving Drug Development Challenges with Model-Based Meta-Analysis (MBMA) Blog Post
Summary In this on-demand webinar, "MBMA: Optimizing Drug Development with Aggregate Clinical Trial Data and Predictive Models," Matt Zierhut shares insights on using clinical trial and real-world data. You'll learn...
